Efficiency of bacteriophage therapy against Cronobacter sakazakii in Galleria mellonella (greater wax moth) larvae

Archives of Virology

Volumn 159, Issue 9, 2014, Pages 2253-2261

  Abbasifar, Reza ^a   Kropinski, Andrew M ^a,b   Sabour, Parviz M ^c   Chambers, James R ^c   MacKinnon, Joanne ^b   Malig, Thomas ^b   Griffiths, Mansel W ^a  

^a UNIVERSITY OF GUELPH   (Canada)

^b PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^c AGRICULTURE AND AGRI FOOD CANADA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; ARTICLE; BACTERIOPHAGE; BIOLOGICAL THERAPY; CRONOBACTER SAKAZAKII; DISEASE MODEL; ENTEROBACTERIACEAE INFECTION; GROWTH, DEVELOPMENT AND AGING; ISOLATION AND PURIFICATION; LARVA; LEPIDOPTERA; METHODOLOGY; MICROBIOLOGY; SURVIVAL; TREATMENT OUTCOME; VIROLOGY;

ANIMALS; BACTERIOPHAGES; BIOLOGICAL THERAPY; CRONOBACTER SAKAZAKII; DISEASE MODELS, ANIMAL; ENTEROBACTERIACEAE INFECTIONS; LARVA; LEPIDOPTERA; MYOVIRIDAE; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84907864086     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00705-014-2055-x     Document Type: Article

References (69)

1. Farmer JJ III, Ashbury MA, Hickman FW, Brenner DJ, The Enterobacteriaceae Study Group (1980) Enterobacter sakazakii: a new species of “Enterobacteriaceae” isolated from clinical specimens. Int J Syst Evolut Microbiol 30:569–584
2. Iversen C, Mullane N, McCardell B, Tall BD, Lehner A, Fanning S, Stephan R, Joosten H (2008) Cronobacter gen. nov., a new genus to accommodate the biogroups of Enterobacter sakazakii, and proposal of Cronobacter sakazakii gen. nov., comb. nov., Cronobacter malonaticus sp. nov., Cronobacter turicensis sp. nov., Cronobacter muytjensii sp. nov., Cronobacter dublinensis sp. nov., Cronobacter genomospecies 1, and of three subspecies, Cronobacter dublinensis subsp. dublinensis subsp. nov., Cronobacter dublinensis subsp. lausannensis subsp. nov. and Cronobacter dublinensis subsp. lactaridi subsp. nov. Int J Syst Evolut Microbiol 58:1442–1447
3. Iversen C, Lehner A, Mullane N, Bidlas E, Cleenwerck I, Marugg J, Fanning S, Stephan R, Joosten H (2007) The taxonomy of Enterobacter sakazakii: proposal of a new genus Cronobacter gen. nov. and descriptions of Cronobacter sakazakii comb. nov. Cronobacter sakazakii subsp. sakazakii, comb. nov., Cronobacter sakazakii subsp. malonaticus subsp. nov., Cronobacter turicensis sp. nov., Cronobacter muytjensii sp. nov., Cronobacter dublinensis sp. nov. and Cronobacter genomospecies 1. BMC Evolut Biol 7:64
4. Yan QQ, Condell O, Power K, Butler F, Tall BD, Fanning S (2012) Cronobacter species (formerly known as Enterobacter sakazakii) in powdered infant formula: a review of our current understanding of the biology of this bacterium. J Appl Microbiol 113:1–15
5. Gurtler JB, Kornacki JL, Beuchat LR (2005) Enterobacter sakazakii: a coliform of increased concern to infant health. Int J Food Microbiol 104:1–34
6. Biering G, Karlsson S, Clark NC, Jonsdottir KE, Ludvigsson P, Steingrimsson O (1989) Three cases of neonatal meningitis caused by Enterobacter sakazakii in powdered milk. J Clin Microbiol 27:2054–2056
7. Jaspar AH, Muytjens HL, Kollee LA (1990) Neonatal meningitis caused by Enterobacter sakazakii: milk powder is not sterile and bacteria like milk too! Tijdschrift voor Kindergeneeskunde 58:151–155
8. Bar-Oz B, Preminger A, Peleg O, Block C, Arad I (2001) Enterobacter sakazakii infection in the newborn. Acta Paediatr 90:356–358
9. Simon M, Sabate S, Cristina OA, Bartolome R, Dolores FM (2010) Investigation of a neonatal case of Enterobacter sakazakii infection associated with the use of powdered infant formula. Enfermedades Infecciosas y Microbiologia Clinica 28:713–715
10. Clark NC, Hill BC, O’Hara CM, Steingrimsson O, Cooksey RC (1990) Epidemiologic typing of Enterobacter sakazakii in two neonatal nosocomial outbreaks. Diagn Microbiol Infect Dis 13:467–472
11. Muytjens HL, Zanen HC, Sonderkamp HJ, Kollee LA, Wachsmuth IK, Farmer JJ III (1983) Analysis of eight cases of neonatal meningitis and sepsis due to Enterobacter sakazakii. J Clin Microbiol 18:115–120
12. Noriega FR, Kotloff KL, Martin MA, Schwalbe RS (1990) Nosocomial bacteremia caused by Enterobacter sakazakiki and Leuconostoc mesenteroides resulting from extrinsic contamination of infant formula. Pediatr Infect Dis J 9:447–449
13. Centers for Disease Control and Prevention (CDC) (2002) Enterobacter sakazakii infections associated with the use of powdered infant formula–Tennessee, 2001. MMWR Morb Mortal Wky Rep 51:297–300
14. Bowen AB, Braden CR (2006) Invasive Enterobacter sakazakii disease in infants. Emerg Infect Dis 12:1185–1189
15. Drudy D, Mullane NR, Quinn T, Wall PG, Fanning S (2006) Enterobacter sakazakii: an emerging pathogen in powdered infant formula. Clin Infect Dis 42:996–1002
16. Lai KK (2001) Enterobacter sakazakii infections among neonates, infants, children, and adults. Case reports and a review of the literature. Medicine (Baltimore) 80:113–122
17. International Commission for the Microbiological Specifications of Foods (ICMSF) (2002) Microorganisms in Foods 7: microbiological testing in food safety management. Kluwer Academic: Plenum Publishers. ISBN:0306472627
18. Norberg S, Stanton C, Ross RP, Hill C, Fitzgerald GF, Cotter PD (2012) Cronobacter spp. in powdered infant formula. J Food Prot 75:607–620
19. Ray P, Das A, Gautam V, Jain N, Narang A, Sharma M (2007) Enterobacter sakazakii in infants: novel phenomenon in India. Indian J Med Microbiol 25:408–410
20. Emery CL, Weymouth LA (1997) Detection and clinical significance of extended-spectrum beta-lactamases in a tertiary-care medical center. J Clin Microbiol 35:2061–2067
21. Hawkins RE, Lissner CR, Sanford JP (1991) Enterobacter sakazakii bacteremia in an adult. South Med J 84:793–795
22. Gosney M (2008) Enterobacter sakazakii bacteraemia with multiple splenic abscesses in a 75-year-old woman: a case report. Age Ageing 37:236–237
23. Pribyl C, Salzer R, Beskin J, Haddad RJ, Pollock B, Beville R, Holmes B, Mogabgab WJ (1985) Aztreonam in the treatment of serious orthopedic infections. Am J Med 78:51–56
24. Ongradi J (2002) Vaginal infection by Enterobacter sakazakii. Sex Transm Infect 78:467
25. Carvalho CM, Santos SB, Kropinski AM, Ferreira EC, Azeredo J (2012) Phages as therapeutic tools to control major foodborne pathogens: Campylobacter and Salmonella. In: Kurtböke I (ed) Bacteriophages. InTech, Rijeka, pp 179–214
26. Goodridge LD, Bisha B (2011) Phage-based biocontrol strategies to reduce foodborne pathogens in foods. Bacteriophage 1:130–137
27. Sillankorva SM, Oliveira H, Azeredo J (2012) Bacteriophages and their role in food safety. Int J Microbiol 863945:1–13
28. Henry M, Debarbieux L (2012) Tools from viruses: bacteriophage successes and beyond. Virology 434:151–161
29. Brovko LY, Anany H, Griffiths MW (2012) Bacteriophages for detection and control of bacterial pathogens in food and food-processing environment. Adv Food Nutr Res 67:241–288
30. Harper DR, Anderson J, Enright MC (2011) Phage therapy: delivering on the promise. Therap Deliv 2:935–947
31. Chanishvili N (2012) Phage therapy–history from Twort and d’Herelle through Soviet experience to current approaches. Adv Virus Res 83:3–40
32. Hagens S, Habel A, von AU, von GA, Bläsi U (2004) Therapy of experimental pseudomonas infections with a nonreplicating genetically modified phage. Antimicrob Agents Chemother 48:3817–3822
33. Soothill J (2013) Use of bacteriophages in the treatment of Pseudomonas aeruginosa infections. Expert Rev Anti-Infect Ther 11:909–915
34. Saussereau E, Debarbieux L (2012) Bacteriophages in the experimental treatment of Pseudomonas aeruginosa infections in mice. Adv Virus Res 83:123–141
35. Merabishvili M, De VD, Verbeken G, Kropinski AM, Vandenheuvel D, Lavigne R, Wattiau P, Mast J, Ragimbeau C, Mossong J, Scheres J, Chanishvili N, Vaneechoutte M, Pirnay JP (2012) Selection and characterization of a candidate therapeutic bacteriophage that lyses the Escherichia coli O104:H4 strain from the 2011 outbreak in Germany. PLoS One 7:e52709
36. Pouillot F, Chomton M, Blois H, Courroux C, Noelig J, Bidet P, Bingen E, Bonacorsi S (2012) Efficacy of bacteriophage therapy in experimental sepsis and meningitis caused by a clone O25b:H4-ST131 Escherichia coli strain producing CTX-M-15. Antimicrob Agents Chemother 56:3568–3575
37. McCallin S, Alam SS, Barretto C, Sultana S, Berger B, Huq S, Krause L, Bibiloni R, Schmitt B, Reuteler G, Brussow H (2013) Safety analysis of a Russian phage cocktail: from metagenomic analysis to oral application in healthy human subjects. Virology 443:187–196
38. Smith HW, Huggins MB, Shaw KM (1987) The control of experimental Escherichia coli diarrhoea in calves by means of bacteriophages. J Gen Microbiol 133:1111–1126
39. Smith HW, Huggins MB (1982) Successful treatment of experimental Escherichia coli infections in mice using phage: its general superiority over antibiotics. J Gen Microbiol 128:2–18
40. Capparelli R, Parlato M, Borriello G, Salvatore P, Iannelli D (2007) Experimental phage therapy against Staphylococcus aureus in mice. Antimicrob Agents Chemother 51:2765–2773
41. Dias RS, Eller MR, Duarte VS, Pereira AL, Silva CC, Mantovani HC, Oliveira LL, Silva EA, De Paula SO (2013) Use of phages against antibiotic-resistant Staphylococcus aureus isolated from bovine mastitis. J Anim Sci 91:3930–3939
42. Leszczyski P, Weber-Dabrowska B, Kohutnicka M, Luczak M, Gorecki A, Gorski A (2006) Successful eradication of methicillin-resistant Staphylococcus aureus (MRSA) intestinal carrier status in a healthcare worker–case report. Folia Microbiol 51:236–238
43. Kumari S, Harjai K, Chhibber S (2011) Bacteriophage versus antimicrobial agents for the treatment of murine burn wound infection caused by Klebsiella pneumoniae B5055. J Med Microbiol 60:205–210
44. Hung CH, Kuo CF, Wang CH, Wu CM, Tsao N (2011) Experimental phage therapy in treating Klebsiella pneumoniae-mediated liver abscesses and bacteremia in mice. Antimicrob Agents Chemother 55:1358–1365
45. Loc Carrillo C, Atterbury RJ, el-Shibiny A, Connerton PL, Dillon E, Scott A, Connerton IF (2005) Bacteriophage therapy to reduce Campylobacter jejuni colonization of broiler chickens. Appl Environ Microbiol 71:6554–6563
46. Glavis-Bloom J, Muhammed M, Mylonakis E (2012) Of model hosts and man: using Caenorhabditis elegans, Drosophila melanogaster and Galleria mellonella as model hosts for infectious disease research. Adv Exp Med Biol 710:11–17. doi:10.1007/978-1-4419-5638-5_2.:11-17
47. Scully LR, Bidochka MJ (2006) Developing insect models for the study of current and emerging human pathogens. FEMS Microbiol Lett 263:1–9
48. Takemura-Uchiyama I, Uchiyama J, Kato SI, Inoue T, Ujihara T, Ohara N, Daibata M, Matsuzaki S (2013) Evaluating efficacy of bacteriophage therapy against Staphylococcus aureus infections using a silkworm larval infection model. FEMS Microbiol Lett 347:52–60
49. Jander G, Rahme LG, Ausubel FM (2000) Positive correlation between virulence of Pseudomonas aeruginosa mutants in mice and insects. J Bacteriol 182:3843–3845
50. Ramarao N, Nielsen-LeRoux C, Lereclus D (2012) The insect Galleria mellonella as a powerful infection model to investigate bacterial pathogenesis. J Vis Exp 70:e4392. doi:10.3791/4392
51. Loessner MJ, Neugirg E, Zink R, Scherer S (1993) Isolation, classification and molecular characterization of bacteriophages for Enterobacter species. J Gen Microbiol 139:2627–2633
52. Kim KP, Klumpp J, Loessner MJ (2007) Enterobacter sakazakii bacteriophages can prevent bacterial growth in reconstituted infant formula. Int J Food Microbiol 115:195–203
53. Zhao G, Zhang Q, Yao L, Chen Y (2008) Isolation and characterization of bacteriophages of Enterobacter sakazakii. Wei Sheng Wu Xue Bao (Acta microbiologica Sinica) 48:1373–1377
54. Lee YD, Kim JY, Park JH, Chang H (2011) Genomic analysis of bacteriophage ESP2949-1, which is virulent for Cronobacter sakazakii. Arch Virol 157:199–202
55. Lee YD, Park JH, Chang HI (2011) Genomic sequence analysis of virulent Cronobacter sakazakii bacteriophage ES2. Arch Virol 156:2105–2108
56. Lee YD, Chang HI, Park JH (2011) Complete genomic sequence of virulent Cronobacter sakazakii phage ESSI-2 isolated from swine feces. Arch Virol 156:721–724
57. Abbasifar R, Kropinski AM, Sabour PM, Ackermann HW, Lingohr EJ, Griffiths MW (2012) Complete genome sequence of Cronobacter sakazakii bacteriophage vB_CsaM_GAP161. J Virol 86:13806–13807
58. Abbasifar R, Kropinski AM, Sabour PM, Ackermann HW, Alanis VA, Abbasifar A, Griffiths MW (2013) The genome of Cronobacter sakazakii bacteriophage vB_CsaP_GAP227 suggests a new genus within the Autographivirinae. Genome Announc 1:e00122
59. Abbasifar R, Kropinski AM, Sabour PM, Ackermann HW, Alanis VA, Abbasifar A, Griffiths MW (2012) Genome sequence of Cronobacter sakazakii myovirus vB_CsaM_GAP31. J Virol 86:13830–13831
60. Tóthová L, Celec P, Bábícková J, Gajdosová J, Al-Alami H, Kamodyova N, Drahovská H, Liptáková A, Turna J, Hodosy J (2011) Phage therapy of Cronobacter-induced urinary tract infection in mice. Med Sci Monit 17:BR173–BR178
61. Jamalludeen N, Johnson RP, Friendship R, Kropinski AM, Lingohr EJ, Gyles CL (2007) Isolation and characterization of nine bacteriophages that lyse O149 enterotoxigenic Escherichia coli. Vet Microbiol 124:47–57
62. Kropinski AM, Mazzocco A, Waddell TE, Lingohr E, Johnson RP (2009) Enumeration of bacteriophages by double agar overlay plaque assay. Methods Mol Biol 501:69–76
63. Sambrook J, Russell DW (2001) Molecular cloning: a laboratory manual, 3rd edn. Cold Spring Harbor Press, Cold Spring Harbor
64. Stephens JM (1959) Immune responses of some insects to some bacterial antigens. Can J Microbiol 5:203–228
65. Randhawa MA (2009) Calculation of LD50 values from the method of Miller and Tainter, 1944. J Ayub Med Coll Abbottabad 21:184–185
66. Ivy RA, Farber JM, Pagotto F, Wiedmann M (2013) International Life Science Institute North America Cronobacter (Formerly Enterobacter sakazakii) isolate set. J Food Prot 76:40–51
67. Miled-Bennour R, Ells TC, Pagotto FJ, Farber JM, Kerouanton A, Meheut T, Colin P, Joosten H, Leclercq A, Besse NG (2010) Genotypic and phenotypic characterisation of a collection of Cronobacter (Enterobacter sakazakii) isolates. Int J Food Microbiol 139:116–125
68. Seed KD, Dennis JJ (2009) Experimental bacteriophage therapy increases survival of Galleria mellonella larvae infected with clinically relevant strains of the Burkholderia cepacia complex. Antimicrob Agents Chemother 53:2205–2208
69. Mylonakis E, Ausubel FM, Tang RJ, Calderwood SB (2003) The art of serendipity: killing of Caenorhabditis elegans by human pathogens as a model of bacterial and fungal pathogenesis. Exp Rev Antiinfect Ther 1:167–173